Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

Mutations in NIPAL4 cause skin issues by disrupting lipid layers, but some improvement is seen with topical treatment.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Lipin-1 is important for skin cell differentiation and skin barrier function.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

CPK1 helps root hair growth in Arabidopsis by activating channels for calcium signaling.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

ILC1-like cells can independently cause alopecia areata.

A new type of nerve cell involved in itch perception was discovered.

Different gene mutations cause different types of ichthyosis, with some new mutations found.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Somatic BHD mutations are rare in Japanese renal tumors.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.